Cardlytics IncCDLX
Price$2.64

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
Analyst Coverage
4analysts covering
Consensus: NeutralAs of 18 Aug 2026
FY EPS (est.)
-$2.31next fiscal year
As of 18 Aug 2026
Reporting Calendar
EventExpected Date
Q3 2026 Earnings Release4 Nov 2026
Monitoring Framework
Key Performance Indicators
Cardlytics Monthly Qualified Users (MQUs) Quarterly197M
Cardlytics Adjusted Contribution Per User (ACPU) Quarterly0.1
Adjusted Contribution Margin Quarterly6,060.0%
Watch Items
  • Stabilization of FI partner supply and user base following the departure of Bank of AmericaTrigger: MQUs dropping significantly below 197 millionAction: Re-evaluate long-term revenue growth projections and platform scale assumptions.
  • Execution of sequential growth targets for the remainder of fiscal year 2026Trigger: Failure to achieve sequential growth in billings, revenue, or adjusted contribution in Q2 2026Action: Assess sales execution, advertiser retention, and cost structure to preserve positive Adjusted EBITDA.
  • Compliance with Nasdaq minimum closing bid price requirementTrigger: Closing bid price falling below $1.00 for 30 consecutive business days post-reverse splitAction: Monitor stock performance closely to ensure compliance is maintained before the November 30, 2026 deadline.
Sign in / Sign up to read more

Research as of 19 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.